Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement.

ABSTRACT:

Objectives

This study sought to address a knowledge gap by examining the incidence, timing, and predictors of acute coronary syndrome (ACS) after transcatheter aortic valve replacement (TAVR) in Medicare beneficiaries.

Background

Evidence about incidence and outcomes of ACS after TAVR is scarce.

Methods

We identified Medicare patients who underwent TAVR from 2012 to 2017 and were admitted with ACS during follow-up. We compared outcomes based on the type of ACS: ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), and unstable angina. In patients with non-ST-segment elevation ACS, we compared outcomes based on the treatment strategy (invasive vs. conservative) using inverse probability weighting analysis.

Results

Out of 142,845 patients with T

SUBMITTER: Mentias A 

PROVIDER: S-EPMC7202131 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature